Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically O... Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products. Mehr anzeigen
LOS ANGELES, April 25, 2024 (GLOBE NEWSWIRE) -- via IBN – Nutriband Inc. (NASDAQ: NTRB), a pharmaceutical company with a specific focus on transdermal technologies, today announces it has...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.34 | -5.35433070866 | 6.35 | 7.74 | 5.82 | 62263 | 6.56589074 | CS |
| 4 | 1.93 | 47.3039215686 | 4.08 | 7.74 | 3.75 | 51877 | 5.62221339 | CS |
| 12 | 0.11 | 1.86440677966 | 5.9 | 9.595 | 3.75 | 38599 | 6.15557361 | CS |
| 26 | 1.21 | 25.2083333333 | 4.8 | 9.595 | 3.2 | 37956 | 5.52901306 | CS |
| 52 | 3.58 | 147.325102881 | 2.43 | 9.595 | 1.53 | 29155 | 4.78731213 | CS |
| 156 | 0.53 | 9.67153284672 | 5.48 | 12.32 | 1.53 | 380456 | 9.13374407 | CS |
| 260 | 0.53 | 9.67153284672 | 5.48 | 12.32 | 1.53 | 380456 | 9.13374407 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
